试验透明度

As an essential part of our clinical trial governance, we are committed to elevating your experience with constant communication and data transparency.

Open communication

Collaborative and proactive, our research teams prioritize open communication with stakeholders throughout trials to help you make the right decisions at the right time.

Clarity

We use data and technology to provide personalized, transparent experiences.

Our proprietary technology Clarity is used as standard across all trials we support and fits seamlessly into your existing workflow so you can see how your study is progressing and how your patient data is performing. It does this through simplified data collection with EDC to CTMS to safety database integration and a continuous flow of information that enables data transparency and a secure, holistic view of your clinical study progress near real-time.

This holistic view allows integrated teams within Caidya to transparently share information and data, generating and sharing insights to inform your decisions.

Learn more about Clarity
Gateway to the globe

Speak to a global expert

Discover how our technology and data integration solutions help you safely and efficiently progress your clinical studies with confidence.

联系我们
引领创新

康缔亚最新动态

探索我们的新闻动态,体验卓越服务品质

03/18/2025

Caidya(康缔亚)加强治疗领域领导力,任命Adam Callahan为肿瘤学和血液学负责人

2025年3月13日, 美国北卡罗来纳州罗利——全球领先的中型临床合同研究组织(CRO)康缔亚,今天宣布任命Adam Callahan为负责全球肿瘤学与血液学临床开发领域的副总裁。在这一职位上,他将为...

02/05/2025

Caidya(康缔亚)任命 Brandon Pallott 为首席商务官,推动创新商业计划与市场扩展

2025年1月28日,美国北卡罗来纳州罗利——全球领先的中型临床合同研究组织(CRO)康缔亚,今天宣布任命 Brandon Pallott 为新任首席商务官 (CCO)。Brandon将专注于实施变革...

01/13/2025

Caidya(康缔亚)宣布获得Rubicon Founders 基金1.65亿美元战略融资

2025年1月13日,美国北卡罗来纳州罗利——全球领先的中型临床合同研究组织(CRO)康缔亚,今天宣布成功完成来自Rubicon Founders管理基金的1.65亿美元战略融资。Rubicon Fo...
Skip to toolbar